Among Michael Barry’s stocks, there is a big reverse possibility
Recently I published the list There are 10 Michael Barry stocks. In this article, we will introduce Oscar Health, Inc. Let’s take a look where (NYSE:OSCR) plays against other Michael Burry stocks.
Michael Burry, Founder and Manager Scion Asset Managementbest known for predicting and profiting the collapse of the housing bubble in the mid-2000s. His bold paradoxical bet is well known for being recorded in the book and film The Big Short. Burry’s investment strategy is largely drawn from the rigorous market analysis and principles outlined in Benjamin Graham and David Dodd’s 1934 book Security Analysis. The book defended the merits of financial statement analysis and highlighted the importance of intrinsic value and structured investment principles.
That said, Barry has never been far from putting his own clear stamp on Wall Street’s essential principles. By utilizing complex financial tools such as derivative securities and short selling, Barry accumulates wealth and challenges traditional market wisdom. His 2001 Scion Value Fund Letter provides fascinating insight into his reverse outlook. Burry makes it clear that he is willing to tolerate short-term volatility in order to achieve significant long-term returns. He said:
“I always choose dollar bills that carry a hugely fluctuating discount, rather than dollar bills that sell at a very stable premium.”
He also doesn’t matter about the tactics investors employed to strengthen Scion’s holdings at the end of 2024, about making significant investments in some stocks he believes are undervalued.
In the quarter that ended December 31, 2024, just before Deepseek’s artificial intelligence breakthrough caused a $1.3 trillion surge in Chinese tech stocks, Michael Burry offloaded some of the country’s investments in high-tech stocks. The move comes amidst the high volatility of Chinese stocks, which appeared to have lost faith in Beijing, following the implementation of the stimulus package in late September. Government actions sparked wild gatherings until early October, but momentum waned due to the property crisis, poor economic outlook and the dissatisfaction with the scope of fiscal stimulus the following month.
In this article, we looked into Scion Asset Management’s fourth quarter 13F filing and listed Michael Barry’s stock picks with the highest potential. We ranked companies in ascending order of their potential for rising. These stocks are also popular among elite hedge funds.
Why are hedge funds interested in the stocks they accumulate? The reason is simple. Our research shows that mimic the top stock picks of the best hedge funds can outperform the market. Quarterly Newsletter’s strategy was to select 14 small and large caps per quarter, returning 373.4% since May 2014, surpassing the benchmark by 218 percentage points (For more information, please see here).
Oscar Health, Inc. (OSCR): Big regurgitation in Michael Barry stock
He is a health professional involved in patient close-ups and conversations, demonstrating the company’s commitment to patient care.
Scion Asset Management quarter stake: $2.68 million
Above Analysts as of May 9: 28.03%
Number of hedge fund holders: 107
Oscar Health, Inc. (NYSE:OSCR) is a health insurance company that utilizes a full stack technology platform to provide and manage insurance. Its key operations and services include health insurance plans, technology platform + Oscars and member services. The company focuses on the health insurance sector through telehealth, healthcare-centric technology interfaces and a transparent billing pricing system.
May 7th, Oscar Health, Inc. (NYSE:OSCR) announced first quarter revenue and revenue that exceeded analyst expectations. The company has adjusted earnings per share of $0.92 and its consensus estimate is above $0.81. Quarterly revenue was $3.05 billion, with forecasts of $2.84 billion, up 42% year-on-year from $2.14 billion in the first quarter of 2024. As of March 31, the company had over 2 million members, from 1.45 million the previous year.
Artificial intelligence is another area of growth for the company. During Oscar Health’s fourth quarter results call, CEO Mark Bertolini said the company is rapidly deploying artificial intelligence in additional areas of its business. He said last year the company implemented AI in 11 new use cases. There are another 10 use cases planned for the first quarter of 2025.
The Longleaf Partners Small-Cap Fund is Oscar Health, Inc. Regarding (NYSE:OSCR), the following has been stated: Q4 2024 Investor Letter:
“Oscar Health, Inc. (NYSE: OSCR) – Health insurance and software company Oscar was the top detractor of the quarter, despite being the top contributor of the year. The company has conducted an operational, operational and even stronger quarter, achieving revenue and membership growth of over 60% year-on-year, while moving forward towards its target of an operating profit margin of 5%. Despite operational advances, President Trump’s victory put pressure on quarterly stock prices as uncertainty about the future of the strengthened ACA subsidies set to expire at the end of 2025, and the ACA itself. Oscar still has unundervalued non-earning assets in various regions at different stages, moving from investment modes in several sectors to higher margin management in other regions. We believe this is a long-term positive and highlights the long-term growth potential built into the Oscar. Election-related news contributed to stock volatility later this year, but leveraged it by strategically trimming and adding to the position. It was strong to see both co-founder Josh Kushner and CEO Mark Bertolini (through his foundation) buy more than $10 million in shares in the wake of the election sale. ”
Overall, OSCR 6th place Michael Barrystock’s list has a big reverse chance. While we acknowledge the potential of OSCR as an investment, our belief lies in the belief that some AI stocks provide higher returns and hold a greater commitment to doing it within a shorter time frame. There have been AI stocks that have risen since the beginning of 2025, and the popular AI stocks have lost around 25%. If you’re looking for AI stocks that are more promising than OSCR, but are trading below 5 times the revenue, check out our report on this Cheapest AI stocks.
